These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16206676)

  • 21. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.
    Hayden FG; Atmar RL; Schilling M; Johnson C; Poretz D; Paar D; Huson L; Ward P; Mills RG
    N Engl J Med; 1999 Oct; 341(18):1336-43. PubMed ID: 10536125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.
    Hayden FG; Sugaya N; Hirotsu N; Lee N; de Jong MD; Hurt AC; Ishida T; Sekino H; Yamada K; Portsmouth S; Kawaguchi K; Shishido T; Arai M; Tsuchiya K; Uehara T; Watanabe A;
    N Engl J Med; 2018 Sep; 379(10):913-923. PubMed ID: 30184455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.
    Dobson J; Whitley RJ; Pocock S; Monto AS
    Lancet; 2015 May; 385(9979):1729-1737. PubMed ID: 25640810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment.
    Gillissen A; Höffken G
    Med Microbiol Immunol; 2002 Dec; 191(3-4):165-8. PubMed ID: 12458353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
    Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ
    Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
    Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R
    Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
    Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T
    Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.
    Ison MG; Portsmouth S; Yoshida Y; Shishido T; Mitchener M; Tsuchiya K; Uehara T; Hayden FG
    Lancet Infect Dis; 2020 Oct; 20(10):1204-1214. PubMed ID: 32526195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for Canada.
    O'Brien BJ; Goeree R; Blackhouse G; Smieja M; Loeb M
    Value Health; 2003; 6(2):116-25. PubMed ID: 12641862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials.
    Ebell MH; Call M; Shinholser J
    Fam Pract; 2013 Apr; 30(2):125-33. PubMed ID: 22997224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study.
    Bachert C; Chuchalin AG; Eisebitt R; Netayzhenko VZ; Voelker M
    Clin Ther; 2005 Jul; 27(7):993-1003. PubMed ID: 16154478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population.
    Peters PH; Gravenstein S; Norwood P; De Bock V; Van Couter A; Gibbens M; von Planta TA; Ward P
    J Am Geriatr Soc; 2001 Aug; 49(8):1025-31. PubMed ID: 11555062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Trujillo A; Barnes J; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2015 Jun; 15(6):654-62. PubMed ID: 25788164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with oseltamivir in the control of nursing home influenza A outbreak.
    Shijubo N; Yamada G; Takahashi M; Tokunoh T; Suzuki T; Abe S
    Intern Med; 2002 May; 41(5):366-70. PubMed ID: 12058885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
    Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
    N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
    Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD
    Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma.
    Johnston SL; Ferrero F; Garcia ML; Dutkowski R
    Pediatr Infect Dis J; 2005 Mar; 24(3):225-32. PubMed ID: 15750458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.
    Kaiser L; Wat C; Mills T; Mahoney P; Ward P; Hayden F
    Arch Intern Med; 2003 Jul; 163(14):1667-72. PubMed ID: 12885681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antivirals for influenza in healthy adults: systematic review.
    Jefferson T; Demicheli V; Rivetti D; Jones M; Di Pietrantonj C; Rivetti A
    Lancet; 2006 Jan; 367(9507):303-13. PubMed ID: 16443037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.